Gold prices bounce off 3-week lows; demand likely longer term
CHARLOTTE, N.C. - Dentsply Sirona Inc. (NASDAQ:XRAY), a leading manufacturer of professional dental products and technologies, has appointed Matthew E. Garth as its new Executive Vice President and Chief Financial Officer, starting May 30, 2025. Mr. Garth’s nearly three decades of financial management experience is expected to contribute to the company’s strategic growth and shareholder value. According to InvestingPro data, the company currently maintains a strong dividend track record, having sustained payments for 32 consecutive years, with analysts expecting improved profitability in the coming year.
Prior to joining Dentsply Sirona, Garth served in key financial roles at The Scotts Miracle-Gro Company (NYSE:SMG), Minerals Technologies Inc. (NYSE:MTX), and Alcoa Corporation, demonstrating a consistent track record of financial leadership and value creation. His expertise in organizational transformation and investor relations is seen as a valuable asset for Dentsply Sirona’s ongoing evolution in the dental industry.
Simon Campion, President and CEO of Dentsply Sirona, expressed confidence in Garth’s ability to enhance the company’s financial, operational, and strategic objectives. Garth himself is eager to contribute to Dentsply Sirona’s mission, focusing on disciplined execution and long-term profitable growth.
Dentsply Sirona, headquartered in Charlotte, North Carolina, prides itself on over a century of service to the dental sector. The company’s comprehensive product offerings are designed to advance patient care and promote safer dental practices globally.
This executive transition comes at a pivotal time for Dentsply Sirona as it seeks to reinforce its market position and drive sustainable growth. The announcement is based on a press release statement from Dentsply Sirona.
In other recent news, Dentsply Sirona Inc. reported its first-quarter 2025 earnings, which exceeded analyst expectations. The company announced an adjusted earnings per share (EPS) of $0.43, surpassing the projected $0.3036, while revenue reached $879 million, slightly above the anticipated $859.26 million. Despite a 7.7% year-over-year decline in revenue, Dentsply Sirona managed to expand its adjusted EBITDA margins by 220 basis points, indicating improved operational efficiency. Additionally, the company held its annual stockholders’ meeting, where all eleven director nominees were elected, and Deloitte and Touche LLP were ratified as the independent auditors for 2025. The stockholders also approved an amendment to the 2024 Omnibus Incentive Plan, increasing the number of shares issuable under the plan by 11,260,000 shares. Furthermore, Dentsply Sirona continues to focus on innovation, with enhancements in its DS Core ecosystem and PrimeScan technology. The company anticipates a 2-4% decline in organic sales for the remainder of 2025, with adjusted EPS expected to range between $1.80 and $2.00. Analyst firms such as Evercore ISI and Leerink Partners have shown interest in the company’s strategic direction and responses to economic challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.